An exceptional opportunity to acquire a leading UK business specialising in pneumatic tube systems (PTS) for healthcare and high-compliance environments. The group combines over three decades of engineering expertise with exclusive UK distribution rights for a market-leading solution, serving NHS Trusts, private hospitals, laboratories, and industrial clients nationwide.
The business delivers a complete solution—from design, installation, and commissioning through to long-term servicing and upgrades—ensuring strong client retention and recurring revenues. With an established reputation across NHS frameworks and private healthcare providers, it operates in a high-barrier, regulation-driven market where trust and compliance are critical.
Financial Summary:
Combined turnover (2021–2024): £7.8m
Combined adjusted EBITDA (2021–2024): £1.1m
2024 revenue: £1.76m with EBITDA of £639k (core business)
Group projected revenue: £5.1m+ by 2028
Forecast adjusted EBITDA: £1.49m by 2028
The business is lean, scalable, and generates recurring revenues through multi-year service agreements, with margins expected to strengthen further over the next 3–5 years.
Opportunity for Buyer;
This sale presents a rare chance to acquire a profitable, high-growth platform in a mission-critical healthcare niche. Benefits include:
Exclusive UK distribution rights for a leading international system.
Immediate access to long-standing NHS and private sector relationships, bypassing years of reputation-building.
Recurring revenues from multi-year service and maintenance contracts.
Clear scalability potential through regional hubs, adjacent market expansion (logistics, pharma, finance, airports), and digital marketing investment.
ESG alignment and a formal Carbon Reduction Plan, appealing to public-sector procurement requirements.
This turnkey platform is ideally suited to trade buyers in healthcare infrastructure, M&E services, automation specialists, or private equity investors seeking exposure to high-margin, recurring-revenue markets.
